DMCPA
Pharmaceutical compound
From Wikipedia, the free encyclopedia
DMCPA, also known as 2,5-dimethoxy-4-methylphenylcyclopropylamine, is a psychedelic drug of the phenethylamine, amphetamine, and phenylcyclopropylamine families related to DOM.[1] It is a derivative of tranylcypromine and is the cyclized phenethylamine analogue of DOM in which the α and β positions have been connected with a carbon atom to form a cyclopropyl group.[1]
- None
 | |
 | |
| Clinical data | |
|---|---|
| Other names | 25D-CPA; 2,5-Dimethoxy-4-methylphenylcyclopropylamine |
| Routes of administration | Oral[1] |
| Drug class | Serotonin receptor modulator; Serotonergic psychedelic; Hallucinogen |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C12H17NO2 |
| Molar mass | 207.273 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Use and effects
In Alexander Shulgin's book PiHKAL (Phenethylamines I Have Known and Loved), the dose range is listed as 15 to 20 mg and the duration is listed as 4 to 8 hours.[1] DMCPA produces open-eye visuals, anorexia, and psychedelic dreams.[1] One of the reports in PiHKAL gave it a +++ on the Shulgin Rating Scale.[1]
Interactions
Pharmacology
Chemistry
Synthesis
The chemical synthesis of DMCPA has been described.[1]
History
DMCPA was first described in the scientific literature by at least 1974.[3]
Society and culture
Legal status
United Kingdom
This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[4]